The Atypical Urothelial Cancer Patient: Management of Bladder Cancers of Non-Transitional Cell Histology and Cancers of the Ureters and Renal Pelvis

Seminars in Oncology

Volumn 34, Issue 2, 2007, Pages 145-153

  Gilligan, Timothy ^a   Dreicer, Robert ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; GEMCITABINE; IFOSFAMIDE; PACLITAXEL;

ARTICLE; BLADDER CANCER; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; KIDNEY PELVIS CANCER; NEPHROURETERECTOMY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; URACHUS; URETER CANCER; UROGENITAL TRACT CANCER;

ADENOCARCINOMA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; SCHISTOSOMIASIS HAEMATOBIA; URACHUS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 33947207889     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.12.005     Document Type: Article

References (94)

1. Billis A., Schenka A.A., Ramos C.C., et al. Squamous and/or glandular differentiation in urothelial carcinoma: Prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol 33 (2001) 631-633
2. El-Sebaie M., Zaghloul M.S., Howard G., et al. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: A review of etiological features, natural history, and management. Int J Clin Oncol 10 (2005) 20-25
3. Lynch C.F., and Cohen M.B. Urinary system. Cancer 75 suppl 1 (1995) 316-329
4. Jozwicki W., Domaniewski J., Skok Z., et al. Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: A mapping study. Urology 66 (2005) 1122-1126
5. Bellmunt J., Ribas A., Eres N., et al. Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma. Cancer 80 (1997) 1966-1972
6. Logothetis C.J., Dexeus F.H., Finn L., et al. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol 8 (1990) 1050-1055
7. Loehrer Sr. P.J., Einhorn L.H., Elson P.J., et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol 10 (1992) 1066-1073
8. Ghoneim M.A., el-Mekresh M.M., el-Baz M.A., et al. Radical cystectomy for carcinoma of the bladder: Critical evaluation of the results in 1,026 cases. J Urol 158 (1997) 393-399
9. Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: A contemporary series. J Urol 165 (2001) 1111-1116
10. Frazier H.A., Robertson J.E., Dodge R.K., et al. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71 (1993) 3993-4001
11. Honma I., Masumori N., Sato E., et al. Local recurrence after radical cystectomy for invasive bladder cancer: An analysis of predictive factors. Urology 64 (2004) 744-748
12. Dahm P., and Gschwend J.E. Malignant non-urothelial neoplasms of the urinary bladder: A review. Eur Urol 44 (2003) 672-681
13. Boucher N.R., Scholefield J.H., and Anderson J.B. The aetiological significance of human papillomavirus in bladder cancer. Br J Urol 78 (1996) 866-869
14. Maloney K.E., Wiener J.S., and Walther P.J. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: Evaluation by differential polymerase chain reaction. J Urol 151 (1994) 360-364
15. Westenend P.J., Stoop J.A., and Hendriks J.G. Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder. BJU Int 88 (2001) 198-201
16. Bickel A., Culkin D.J., and Wheeler Jr. J.S. Bladder cancer in spinal cord injury patients. J Urol 146 (1991) 1240-1242
17. Melzak J. The incidence of bladder cancer in paraplegia. Paraplegia 4 (1966) 85-96
18. Groah S.L., Weitzenkamp D.A., Lammertse D.P., et al. Excess risk of bladder cancer in spinal cord injury: Evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil 83 (2002) 346-351
19. Subramonian K., Cartwright R.A., Harnden P., et al. Bladder cancer in patients with spinal cord injuries. BJU Int 93 (2004) 739-743
20. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: A high risk malignancy?. Urology 59 (2002) 240-244
21. Subramonian K., and Harrison S.C. Re: Bladder histological changes associated with chronic indwelling urinary catheter. J Urol 162 (1999) 2105-2106
22. Hess M.J., Zhan E.H., Foo D.K., et al. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 26 (2003) 335-338
23. Yang C.C., and Clowers D.E. Screening cystoscopy in chronically catheterized spinal cord injury patients. Spinal Cord 37 (1999) 204-207
24. Hamid R., Bycroft J., Arya M., et al. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: Is it valid?. J Urol 170 (2003) 425-427
25. West D.A., Cummings J.M., Longo W.E., et al. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 53 (1999) 292-297
26. Jones M.A., Bloom H.J., Williams G., et al. The management of squamous cell carcinoma of the bladder. Br J Urol 52 (1980) 511-514
27. Tannenbaum S.I., Carson III C.C., Tatum A., et al. Squamous carcinoma of urinary bladder. Urology 22 (1983) 597-599
28. Richie J.P., Waisman J., Skinner D.G., et al. Squamous carcinoma of the bladder: Treatment by radical cystectomy. J Urol 115 (1976) 670-672
29. Serretta V., Pomara G., Piazza F., et al. Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol 37 (2000) 85-89
30. Rundle J.S., Hart A.J., McGeorge A., et al. Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol 54 (1982) 522-526
31. Navon J.D., Soliman H., Khonsari F., et al. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol 157 (1997) 2109-2111
32. Wolchok J.D., Herr H.W., and Kelly W.K. Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretion. Urology 51 (1998) 489-491
33. Swanson D.A., Liles A., and Zagars G.K. Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol 143 (1990) 37-40
34. Quilty P.M., and Duncan W. Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 12 (1986) 861-865
35. Galsky M.D., Iasonos A., Mironov S., et al. Prospective trial of ifosfamide, paclitaxel, and cisplatin (ITP) in patients with advanced non-transitional cell (non-TCC) carcinomas of the urothelial tract. Proc Am Soc Clin Oncol 24 (2006) 227S (abstr 4542)
36. Hassan N., Mounir M., El-Basmi A., et al. Statistical Report for NCI. Volume 2006 (2001), National Cancer Institute, Cairo, Egypt
37. Mostafa M.H., Sheweita S.A., and O'Connor P.J. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 12 (1999) 97-111
38. Shokeir A.A. Squamous cell carcinoma of the bladder: Pathology, diagnosis and treatment. BJU Int 93 (2004) 216-220
39. Khaled H., El Hattab O., Moneim D.A., et al. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer. Urol Oncol 23 (2005) 254-260
40. Ghoneim M.A., Ashamallah A.K., Awaad H.K., et al. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134 (1985) 266-268
41. Zaghloul M.S., Awwad H.K., Akoush H.H., et al. Postoperative radiotherapy of carcinoma in bilharzial bladder: Improved disease free survival through improving local control. Int J Radiat Oncol Biol Phys 23 (1992) 511-517
42. Khaled H., Zaghloul M., Ghoneim M., et al. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive bladder cancer: Effect on bladder preservation and survival. Proc Am Soc Clin Oncol 22 (2003) 411 (abstr 1652)
43. Zaghloul M., Khaled H., Loutayef M., et al. A phase III randomized controlled trial of adjuvant chemoradiotherapy (CRT) and postoperative radiotherapy (PORT) versus PORT alone in high risk bladder cancer patients. Proc Am Soc Clin Oncol 23 (2005) 398S (abstr 4584)
44. Zaghloul M.S. Distant metastasis from bilharzial bladder cancer. Cancer 77 (1996) 743-749
45. Khaled H.M., Hamza M.R., Mansour O., et al. A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma. Eur J Cancer 36 suppl 2 (2000) 34-37
46. Khaled H.M., Gad el-Mawla N., el-Said A., et al. Combination chemotherapy for advanced bilharzial bladder carcinoma. Ann Oncol 7 (1996) 751-754
47. Gad-el-Mawla N., Hamza M.R., Zikri Z.K., et al. Chemotherapy in invasive carcinoma of the bladder. A review of phase II trials in Egypt. Acta Oncol 28 (1989) 73-76
48. Zaghloul M.S., Nouh A., Nazmy M., et al. Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients. Urol Oncol 24 (2006) 13-20
49. el-Mekresh M.M., el-Baz M.A., Abol-Enein H., et al. Primary adenocarcinoma of the urinary bladder: A report of 185 cases. Br J Urol 82 (1998) 206-212
50. Wilson T.G., Pritchett T.R., Lieskovsky G., et al. Primary adenocarcinoma of bladder. Urology 38 (1991) 223-226
51. Bates A.W., and Baithun S.I. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: Clinicopathological and histological features of 282 cases. Histopathology 36 (2000) 32-40
52. Filmer R.B., and Spencer J.R. Malignancies in bladder augmentations and intestinal conduits. J Urol 143 (1990) 671-678
53. Shokeir A.A., Shamaa M., el-Mekresh M.M., et al. Late malignancy in bowel segments exposed to urine without fecal stream. Urology 46 (1995) 657-661
54. Wang H.L., Lu D.W., Yerian L.M., et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 25 (2001) 1380-1387
55. Bardales R.H., Pitman M.B., Stanley M.W., et al. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer 84 (1998) 335-343
56. Edgerton M.E., Hoda R.S., and Gupta P.K. Cytologic diagnosis of metastatic ovarian adenocarcinoma in the urinary bladder: A case report and review of the literature. Diagn Cytopathol 20 (1999) 156-159
57. Nakanishi K., Tominaga S., Kawai T., et al. Mucin histochemistry in primary adenocarcinoma of the urinary bladder (of urachal or vesicular origin) and metastatic adenocarcinoma originating in the colorectum. Pathol Int 50 (2000) 297-303
58. Pantuck A.J., Murphy D.P., Amenta P.S., et al. The monoclonal antibody 7E12H12 can differentiate primary adenocarcinoma of the bladder and prostate. Br J Urol 82 (1998) 426-430
59. Paulhac P., Maisonnette F., Bourg S., et al. Adenocarcinoma in the exstrophic bladder. Urology 54 (1999) 744
60. Grignon D.J., Ro J.Y., Ayala A.G., et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer 67 (1991) 2165-2172
61. Dandekar N.P., Dalal A.V., Tongaonkar H.B., et al. Adenocarcinoma of bladder. Eur J Surg Oncol 23 (1997) 157-160
62. Siefker-Radtke A.O., Gee J., Shen Y., et al. Multimodality management of urachal carcinoma: The M.D. Anderson Cancer Center experience. J Urol 169 (2003) 1295-1298
63. Cothren C., Ferucci P., Harken A.H., et al. Urachal carcinoma: Key points for the general surgeon. Am Surg 68 (2002) 201-203
64. Herr H.W. Urachal carcinoma: The case for extended partial cystectomy. J Urol 151 (1994) 365-366
65. Henly D.R., Farrow G.M., and Zincke H. Urachal cancer: Role of conservative surgery. Urology 42 (1993) 635-639
66. Quek M.L., Nichols P.W., Yamzon J., et al. Radical cystectomy for primary neuroendocrine tumors of the bladder: The University of Southern California experience. J Urol 174 (2005) 93-96
67. Choong N.W., Quevedo J.F., and Kaur J.S. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103 (2005) 1172-1178
68. Bex A., Nieuwenhuijzen J.A., Kerst M., et al. Small cell carcinoma of bladder: A single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 65 (2005) 295-299
69. Siefker-Radtke A.O., Dinney C.P., Abrahams N.A., et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: A retrospective review of the M.D. Anderson cancer experience. J Urol 172 (2004) 481-484
70. Mangar S.A., Logue J.P., Shanks J.H., et al. Small-cell carcinoma of the urinary bladder: 10-year experience. Clin Oncol (R Coll Radiol) 16 (2004) 523-527
71. Cheng L., Pan C.X., Yang X.J., et al. Small cell carcinoma of the urinary bladder: A clinicopathologic analysis of 64 patients. Cancer 101 (2004) 957-962
72. Cheng L., Jones T.D., McCarthy R.P., et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 166 (2005) 1533-1539
73. Lohrisch C., Murray N., Pickles T., et al. Small cell carcinoma of the bladder: Long term outcome with integrated chemoradiation. Cancer 86 (1999) 2346-2352
74. Kirkali Z., and Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47 (2003) 155-169
75. Cohen R.A., and Brown R.S. Clinical practice. Microscopic hematuria. N Engl J Med 348 (2003) 2330-2338
76. Tolley D.A., and Esposito M.P. Laparoscopic and renal sparing approaches to tumours of the ureter and kidney. Surg Oncol 11 (2002) 47-54
77. McNeill A., Oakley N., Tolley D.A., et al. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: A critical appraisal. BJU Int 94 (2004) 259-263
78. Johnson G.B., and Grasso M. Ureteroscopic management of upper urinary tract transitional cell carcinoma. Curr Opin Urol 15 (2005) 89-93
79. Daneshmand S., Quek M.L., and Huffman J.L. Endoscopic management of upper urinary tract transitional cell carcinoma: Long-term experience. Cancer 98 (2003) 55-60
80. Lee B.R., Jabbour M.E., Marshall F.F., et al. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: Equivalent outcomes. J Endourol 13 (1999) 289-294
81. Elliott D.S., Segura J.W., Lightner D., et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma?. Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 58 (2001) 174-178
82. Goel M.C., Mahendra V., and Roberts J.G. Percutaneous management of renal pelvic urothelial tumors: Long-term followup. J Urol 169 (2003) 925-929
83. Jabbour M.E., and Smith A.D. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am 27 (2000) 739-750
84. Thalmann G.N., Markwalder R., Walter B., et al. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168 (2002) 1381-1385
85. Irie A., Iwamura M., Kadowaki K., et al. Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology 59 (2002) 53-57
86. Bassi P., Iafrate M., Longo F., et al. Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract. A review of the literature. Urol Int 67 (2001) 189-194
87. Nonomura N., Ono Y., Nozawa M., et al. Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol 38 (2000) 701-704
88. Oehlschlager S., Baldauf A., Wiessner D., et al. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract. Urol Int 73 (2004) 209-211
89. Chen G.L., and Bagley D.H. Ureteroscopic surgery for upper tract transitional-cell carcinoma: Complications and management. J Endourol 15 (2001) 399-404
90. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
91. Bajorin D.F., Dodd P.M., Mazumdar M., et al. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. Journal of Clinical Oncology 17 (1999) 3173-3181
92. Bamias A., Deliveliotis C., Fountzilas G., et al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: A study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22 (2004) 2150-2154
93. Vaughn D.J., Manola J., Dreicer R., et al. Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): A trial of the Eastern Cooperative Oncology Group. Cancer 95 (2002) 1022-1027
94. Dreicer R., Manola J., Roth B.J., et al. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium. Cancer 100 (2004) 1639-1645